Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which dose of painkiller works best after C-Section?

NCT ID NCT07244757

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two different doses of a painkiller called ketorolac given through an IV after cesarean delivery. 125 women having planned C-sections took part. The goal was to see which dose provides better pain relief as part of a standard pain management plan.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ketorolac
What this could lead to
If successful, this could help doctors choose the best dose of ketorolac for managing pain after C-section, improving comfort and reducing side effects.
What could go wrong
This is a small, completed trial comparing two doses of a common drug. The results may not apply to all patients or settings, and the difference between doses might be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

125 people

The number who actually took part.

Started

Dec 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * full-term, singleton, pregnant women, * aged 18-35 years, * scheduled for elective cesarean delivery under spinal anesthesia Exclusion Criteria: * American Society of Anesthesiologists (ASA) physical class III or more * multiple gestation. Patients with a history of allergy to any of the study drugs, * renal impairment, * gastrointestinal bleeding or ulceration * inflammatory bowel disease, * chronic pain or regular opioid use. * Inability to comprehend the numeric pain scale (NRS) or the ObsQoR-11 score * requirement for conversion to general anesthesia after spinal anesthesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean delivery Ketorolac Postoperative analgesia

Contacts and locations

Locations

  • Kasr Alainy Hospital

    Cairo, 11562, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.